HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo

This article was originally published in The Tan Sheet

Executive Summary

Private label version of Whitehall-Robins' Advil Cold & Sinus, available in 20- and 40-count bottles, began shipping Oct. 8. Perrigo is marketing product under licensing agreement with Ranbaxy Pharmaceuticals subsidiary Ohm Labs (1"The Tan Sheet" May 7, p. 8). As first to file ANDA for ibuprofen 200 mg/pseudoephedrine 30 mg combo, Ohm was granted 180-day marketing exclusivity effective April 17
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

RS131460

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel